Proactive therapy: New perspectives for long‐term topical treatment of psoriasis
- 8 February 2022
- journal article
- research article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 35 (5) , e15364
Abstract
Mild to moderate psoriasis is most often treated with topical therapy. The article reviews literature on topical treatments that have been assessed in clinical trials and real-life studies lasting at least 12 months. Calcipotriol/bethamethasone dipropionate foam in maintenance treatment following the induction phase can improve efficacy and safety of topical therapy in psoriatic patients. Introduction of new topical nonsteroidal drugs and the wider use of proactive therapy seem to be crucial to achieve satisfactory long-term outcomes in psoriasis.Keywords
This publication has 16 references indexed in Scilit:
- Long-term topical management of psoriasis: the road aheadJournal of Dermatological Treatment, 2020
- Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasisJournal of the American Academy of Dermatology, 2019
- A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)British Journal of Dermatology, 2017
- Proactive treatment with calcipotriol reduces recurrence of plaque psoriasisThe Journal of Dermatology, 2015
- Real‐life effectiveness of once‐daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52‐week PRO‐long studyJournal of the European Academy of Dermatology and Venereology, 2015
- Topical long‐term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practiceJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2014
- Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patientsJournal of Dermatological Treatment, 2013
- A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp PsoriasisDermatology, 2008
- Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis VulgarisDermatology, 2006
- A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet® /Daivobet® /Taclonex® ) in the treatment of psoriasis vulgarisBritish Journal of Dermatology, 2006